The RM.com platform is designed, developed and operated by
Avance, the valuation and advisory firm based out of Basel, Switzerland since 2004. We have almost a decade of experience in royalty monetization transactions working with most of the royalty monetization financers in the space.Together with our legal partner: Ropes & Gray we can offer a one-stop global solution for royalty monetization for biopharma companies against an unmatched fee structure and convenience.
The calculations are processed through our proprietary valuation and licensing platform RIVAL. The overarching objective of the RIVAL platform is to empower biotech executives around the world to capture the value they create by developing therapeutic assets for improving people's lives.
.png){kind=avatar}
.png)
